XML 26 R16.htm IDEA: XBRL DOCUMENT v3.19.1
JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended 77 Months Ended
Aug. 11, 2017
Jul. 14, 2017
Aug. 03, 2012
Oct. 27, 2017
Aug. 31, 2017
Aug. 25, 2016
Mar. 31, 2016
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Dec. 31, 2018
Related Party Transaction [Line Items]                      
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures     $ 6,000,000         $ 6,000,000      
Joint Venture Investments In Voting Common Ownership Units (in shares)     600,000                
Joint Venture Investments In Non Voting Preferred Ownership Units     5,000,000                
Joint Venture, Operating Expenses, Inter Company Transactions               684,000     $ 10,282,000
Joint Venture, Operating Expenses Allocated To Company                     8,670,000
Percentage Of Non Royalty Income 5.00%   5.00%                
Conversion of Stock, Shares Converted (3,500,000)                    
Conversion of Stock, Shares Issued             120,000        
Joint Venture Method Investment Ownership Percentage     60.00%                
Proceeds from Issuance of Preferred Stock and Preference Stock               0      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           33,088          
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 10.70          
Management Fees               50,000      
Operating Expenses Net Of Elimination Of Intercompany Transactions               684,000      
Conversion of Stock, Amount Converted $ 3,500,000                    
Conversion of Stock, Amount Issued $ 1,000,000                    
Interest Payable               $ 249,000   $ 213,000 $ 213,000
Accrued Professional Fees         $ 20,000            
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                   83,480 83,480
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       14,126              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price       $ 10.70              
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage                   50.00%  
Ownership As Converted [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Method Investment Ownership Percentage                   65.11%  
Ownership As Converted Including Options And Warrants [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Method Investment Ownership Percentage       64.31%              
Joint Venture [Member]                      
Related Party Transaction [Line Items]                      
Noncontrolling Interest, Ownership Percentage by Parent               100.00%      
Series B1 Preferred Stock [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Losses Recognition Criteria, Common Ownership Equity           $ 946,000          
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           1,012,000          
Proceeds from Issuance of Preferred Stock and Preference Stock           946,000          
Payments of Stock Issuance Costs           $ 66,000          
Stock Issued During Period, Shares, New Issues           94,537          
Management Fees         $ 300,000            
Management Fee Expense               $ 150,000 $ 150,000    
Accrued Professional Fees               400,000      
Series B2 Preferred Stock [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Losses Recognition Criteria, Common Ownership Equity           $ 946,000          
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           $ 1,012,000          
Proceeds from Issuance of Preferred Stock and Preference Stock               946,000      
Payments of Stock Issuance Costs   $ 287,000                  
Stock Issued During Period, Shares, Acquisitions 93,458       93,458 93,458          
Stock Issued During Period, Value, Acquisitions $ 1,000,000       $ 1,000,000 $ 1,000,000          
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs $ 15,000                    
Series B1 And B2 Preferred Stock [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Method Investment Ownership Percentage     62.20%                
Series A Preferred Stock [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Method Investment Ownership Percentage     69.75%                
Revolving Credit Facility [Member]                      
Related Party Transaction [Line Items]                      
Long-term Line of Credit               1,740,000      
Interest Payable               140,000      
Preferred Stock [Member]                      
Related Party Transaction [Line Items]                      
Conversion of Stock, Shares Converted             1,500,000        
Noncontrolling Interest [Member]                      
Related Party Transaction [Line Items]                      
Noncash or Part Noncash Acquisition, Other Liabilities Assumed                     $ 667,000
Maximum [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Method Investment Ownership Percentage             64.00%        
Minimum [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Method Investment Ownership Percentage             60.00%        
Exclusive License Agreement [Member]                      
Related Party Transaction [Line Items]                      
Percentage Of Royalty Payment           3.00%          
Annual Maintenance Payments           $ 25,000          
Exclusive License Agreement [Member] | Maximum [Member]                      
Related Party Transaction [Line Items]                      
Milestone Payments           500,000          
Royalty Expense     $ 1,000,000                
Exclusive License Agreement [Member] | Minimum [Member]                      
Related Party Transaction [Line Items]                      
Milestone Payments           $ 50,000          
Royalty Expense     $ 500,000                
Lipimetix [Member]                      
Related Party Transaction [Line Items]                      
Joint Venture Investments Common Ownership Units, Co-venture (in shares)     400,000                
Ownership Percentage Co-venture     40.00%                
Noncash or Part Noncash Acquisition, Other Liabilities Assumed               667,000      
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)     $ 378,000         $ 378,000      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                   81,479  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                   $ 1.07  
Voting Common Ownership Units [Member]                      
Related Party Transaction [Line Items]                      
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures     1,000,000                
Non Voting Preferred Ownership Units [Member]                      
Related Party Transaction [Line Items]                      
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures     $ 5,000,000